Support of a molecular tumour board by an evidence-based decision management system for precision oncology.
European Journal of Cancer(2020)
摘要
•Evidence-based, flexible workflow for the clinical interpretation of molecular data.•Application to complex data including whole-exome sequencing and RNA-Sequencing in clinical routine.•Initiation of targeted treatment in 39% of patients.•Promising responses in a subset of patients.•Standardisation of precision oncology workflows could help improve prospective trials.
更多查看译文
关键词
Precision oncology,Molecular tumour board,Molecular tumour conference,Targeted therapy,Personalized therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络